LIVER CANCER (FIBROLAMELLAR HEPATOCELLULAR CANCER (FLC))

Clinical trials for LIVER CANCER (FIBROLAMELLAR HEPATOCELLULAR CANCER (FLC)) explained in plain language.

Never miss a new study

Get alerted when new LIVER CANCER (FIBROLAMELLAR HEPATOCELLULAR CANCER (FLC)) trials appear

Sign up with your email to follow new studies for LIVER CANCER (FIBROLAMELLAR HEPATOCELLULAR CANCER (FLC)), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New targeted vaccine combo tested for rare liver cancer

Disease control Not yet recruiting

This early-stage study is testing a new combination treatment for people with advanced fibrolamellar hepatocellular carcinoma (FLC), a rare type of liver cancer. The treatment combines a personalized vaccine that targets a specific cancer marker with three other drugs designed to…

Matched conditions: LIVER CANCER (FIBROLAMELLAR HEPATOCELLULAR CANCER (FLC))

Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

LIVER CANCER (FIBROLAMELLAR HEPATOCELLULAR CANCER (FLC))

Get alerted when new LIVER CANCER (FIBROLAMELLAR HEPATOCELLULAR CANCER (FLC)) trials appear

New targeted vaccine combo tested for rare liver cancer